A review of SARS-CoV-2 variants and vaccines: Viral properties, mutations, vaccine efficacy, and safety
The severe acute respiratory syndrome coronavirus disease 2 instigated by coronavirus disease of 2019 (COVID-19) has delivered an unfathomable obstruction that has touched all sectors worldwide. Despite new vaccine technologies and mass administration of booster doses, the virus persists, and unknow...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-12-01
|
| Series: | Infectious Medicine |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772431X23000448 |
| _version_ | 1797342099660603392 |
|---|---|
| author | Md. Aminul Islam |
| author_facet | Md. Aminul Islam |
| author_sort | Md. Aminul Islam |
| collection | DOAJ |
| description | The severe acute respiratory syndrome coronavirus disease 2 instigated by coronavirus disease of 2019 (COVID-19) has delivered an unfathomable obstruction that has touched all sectors worldwide. Despite new vaccine technologies and mass administration of booster doses, the virus persists, and unknown the ending of the pandemic for new variants and sub-variants. Moreover, whether leaning on home medications or using plant extracts is sufficient often to combat the virus has generated tremendous interest in the scientific fraternity. Different databases including PubMed, Scopus, Web of Science, and Google Scholar used to find published articles linked with related topics. Currently, COVID-19 third and fourth shots of vaccines are progressively administered worldwide, where some countries trail others by a significant margin. Many proteins related to viral activity have changed, possibly boosting the virus infectivity and making antibodies ineffective. This study will reminisce the viral genome, associated pathways for viral protein functions, variants, and their mutations. The current, comprehensive review will also provide information on vaccine technologies developed by several biotech companies and the efficacy of their doses, costs including boosters on a mass level. As no vaccine is working to protect fully against all the variants, the new proactive vaccine research needs to be conducted based on all variants, their sub-lineage, and mutations. |
| first_indexed | 2024-03-08T10:28:31Z |
| format | Article |
| id | doaj.art-5d5a59ff01244ab09470faa829eeb108 |
| institution | Directory Open Access Journal |
| issn | 2772-431X |
| language | English |
| last_indexed | 2024-03-08T10:28:31Z |
| publishDate | 2023-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Infectious Medicine |
| spelling | doaj.art-5d5a59ff01244ab09470faa829eeb1082024-01-27T07:00:44ZengElsevierInfectious Medicine2772-431X2023-12-0124247261A review of SARS-CoV-2 variants and vaccines: Viral properties, mutations, vaccine efficacy, and safetyMd. Aminul Islam0Advanced Molecular Lab, Department of Microbiology, President Abdul Hamid Medical College, Karimganj 2310, Bangladesh; COVID-19 Diagnostic lab, Department of Microbiology, Noakhali Science and Technology University, Noakhali 3814, BangladeshThe severe acute respiratory syndrome coronavirus disease 2 instigated by coronavirus disease of 2019 (COVID-19) has delivered an unfathomable obstruction that has touched all sectors worldwide. Despite new vaccine technologies and mass administration of booster doses, the virus persists, and unknown the ending of the pandemic for new variants and sub-variants. Moreover, whether leaning on home medications or using plant extracts is sufficient often to combat the virus has generated tremendous interest in the scientific fraternity. Different databases including PubMed, Scopus, Web of Science, and Google Scholar used to find published articles linked with related topics. Currently, COVID-19 third and fourth shots of vaccines are progressively administered worldwide, where some countries trail others by a significant margin. Many proteins related to viral activity have changed, possibly boosting the virus infectivity and making antibodies ineffective. This study will reminisce the viral genome, associated pathways for viral protein functions, variants, and their mutations. The current, comprehensive review will also provide information on vaccine technologies developed by several biotech companies and the efficacy of their doses, costs including boosters on a mass level. As no vaccine is working to protect fully against all the variants, the new proactive vaccine research needs to be conducted based on all variants, their sub-lineage, and mutations.http://www.sciencedirect.com/science/article/pii/S2772431X23000448SARS-CoV-2Variants & subvariantsVaccinesBooster dosesImmunity |
| spellingShingle | Md. Aminul Islam A review of SARS-CoV-2 variants and vaccines: Viral properties, mutations, vaccine efficacy, and safety Infectious Medicine SARS-CoV-2 Variants & subvariants Vaccines Booster doses Immunity |
| title | A review of SARS-CoV-2 variants and vaccines: Viral properties, mutations, vaccine efficacy, and safety |
| title_full | A review of SARS-CoV-2 variants and vaccines: Viral properties, mutations, vaccine efficacy, and safety |
| title_fullStr | A review of SARS-CoV-2 variants and vaccines: Viral properties, mutations, vaccine efficacy, and safety |
| title_full_unstemmed | A review of SARS-CoV-2 variants and vaccines: Viral properties, mutations, vaccine efficacy, and safety |
| title_short | A review of SARS-CoV-2 variants and vaccines: Viral properties, mutations, vaccine efficacy, and safety |
| title_sort | review of sars cov 2 variants and vaccines viral properties mutations vaccine efficacy and safety |
| topic | SARS-CoV-2 Variants & subvariants Vaccines Booster doses Immunity |
| url | http://www.sciencedirect.com/science/article/pii/S2772431X23000448 |
| work_keys_str_mv | AT mdaminulislam areviewofsarscov2variantsandvaccinesviralpropertiesmutationsvaccineefficacyandsafety AT mdaminulislam reviewofsarscov2variantsandvaccinesviralpropertiesmutationsvaccineefficacyandsafety |